Skin cell study for scleroderma
Part of Skin clinical trials.
This trial collects skin samples from people with scleroderma and from healthy volunteers undergoing plastic surgery. Researchers will study the genes in skin cells to better understand the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have systemic scleroderma
- You are willing to provide a small skin sample (biopsy)
- You are not a minor
- You are able to give informed consent
- You are covered by a national health insurance plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with systemic scleroderma (also called scleroderma) to better understand the condition over time. You may be included if you meet specific diagnosis and blood-test requirements and can give informed consent.
This study builds a registry of people with scleroderma and may store medical information and samples for future research. It can help researchers better understand the disease and develop better treatments.
This study looks at how scleroderma affects physical performance and daily function in children and adults. It aims to understand the impact of the disease on movement and everyday activities.
This study looks at what makes people with scleroderma decide to join clinical trials. By participating, you help doctors understand how to make trials easier and more accessible for patients like you.
This study uses skin samples from people with scleroderma, their relatives, and healthy volunteers to create stem cells in a lab. The goal is to learn more about the disease and find better ways to treat it.
This study compares skin samples from people with scleroderma and healthy volunteers to understand what goes wrong in the skin. It may help researchers find new treatment targets.
Hear when a new Scleroderma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.